What is the address of Dr. Van Laer, Gastroenterologie?

The registered office of Dr. Van Laer, Gastroenterologie is located at Heilsborre 21, 1730 Asse.

Is Dr. Van Laer, Gastroenterologie still active?

Yes. According to the CBE (29 September 2026) Dr. Van Laer, Gastroenterologie is active, legal situation “Normale toestand”, started on 13 November 2019.

Is Dr. Van Laer, Gastroenterologie registered on Peppol?

Yes, Dr. Van Laer, Gastroenterologie is registered on the Peppol network with ID 0208:0737648079.

What is the enterprise number of Dr. Van Laer, Gastroenterologie?

The enterprise number of Dr. Van Laer, Gastroenterologie is BE0737648079.

When was Dr. Van Laer, Gastroenterologie founded?

Dr. Van Laer, Gastroenterologie was founded on 13 November 2019.

Is Dr. Van Laer, Gastroenterologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 November 2019; 5 annual accounts filed, latest fiscal year 2025.

How much profit did Dr. Van Laer, Gastroenterologie make in 2025?

Dr. Van Laer, Gastroenterologie posted a profit after taxes of € 36,707 in financial year 2025.

What is the revenue of Dr. Van Laer, Gastroenterologie?

As a small company, Dr. Van Laer, Gastroenterologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 55,924.

Dr. Van Laer, Gastroenterologie (Private Limited) - Asse

Dossier Dr. Van Laer, Gastroenterologie, printed on 29 September 2026 from databakkes.be/en/0737648079/dr-van-laer-gastroenterologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Van Laer, Gastroenterologie from Asse, company number BE0737648079, closed financial year 2025 with a result of € 36,707 after tax. For that financial year Dr. Van Laer, Gastroenterologie recorded a gross margin of € 55,924 and equity of € 56,684. Compared with financial year 2024, the result moved from € 29,906 to € 36,707. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 26, 2026.

What it is worth Growing

€ 56,684

▲ 13% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 36,707

▲ 23% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 27,962

▼ 23% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 30,000 paid out

82 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 271

▼ 82% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 12,000

▲ 20% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 10,050

▲ 178% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,548

▼ 75% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 41,507 Gross margin 2022: € 41,507 First fiscal year in the series	€ 33,613 Gross margin 2023: € 33,613 ▼ 19% vs 2022 (€ 41,507) Unfavourable step	€ 43,980 Gross margin 2024: € 43,980 ▲ 31% vs 2023 (€ 33,613) Favourable step	€ 55,924 Gross margin 2025: € 55,924 ▲ 27% vs 2024 (€ 43,980) Favourable step	▲ 27%
Profit after taxes	€ 26,023 Profit after taxes 2022: € 26,023 First fiscal year in the series	€ 16,008 Profit after taxes 2023: € 16,008 ▼ 38% vs 2022 (€ 26,023) Unfavourable step	€ 29,906 Profit after taxes 2024: € 29,906 ▲ 87% vs 2023 (€ 16,008) Favourable step	€ 36,707 Profit after taxes 2025: € 36,707 ▲ 23% vs 2024 (€ 29,906) Favourable step	▲ 23%
Equity	€ 69,063 Equity 2022: € 69,063 First fiscal year in the series	€ 55,071 Equity 2023: € 55,071 ▼ 20% vs 2022 (€ 69,063) Unfavourable step	€ 49,977 Equity 2024: € 49,977 ▼ 9% vs 2023 (€ 55,071) Unfavourable step	€ 56,684 Equity 2025: € 56,684 ▲ 13% vs 2024 (€ 49,977) Favourable step	▲ 13%
Total debts	€ 4,992 Total debts 2022: € 4,992 First fiscal year in the series	€ 13,326 Total debts 2023: € 13,326 ▲ 167% vs 2022 (€ 4,992) Unfavourable step	€ 23,941 Total debts 2024: € 23,941 ▲ 80% vs 2023 (€ 13,326) Unfavourable step	€ 24,598 Total debts 2025: € 24,598 ▲ 3% vs 2024 (€ 23,941) Unfavourable step	▲ 3%
Cash	€ 47,904 Cash 2022: € 47,904 First fiscal year in the series	€ 11,644 Cash 2023: € 11,644 ▼ 76% vs 2022 (€ 47,904) Unfavourable step	€ 36,494 Cash 2024: € 36,494 ▲ 213% vs 2023 (€ 11,644) Favourable step	€ 27,962 Cash 2025: € 27,962 ▼ 23% vs 2024 (€ 36,494) Unfavourable step	▼ 23%
Land & buildings	€ 2,462 Land & buildings 2022: € 2,462 First fiscal year in the series	€ 1,418 Land & buildings 2023: € 1,418 ▼ 42% vs 2022 (€ 2,462) Unchanged	€ 374 Land & buildings 2024: € 374 ▼ 74% vs 2023 (€ 1,418) Unchanged	-
Retained profit	€ 64,063 Retained profit 2022: € 64,063 First fiscal year in the series	€ 50,071 Retained profit 2023: € 50,071 ▼ 22% vs 2022 (€ 64,063) Unfavourable step	€ 44,977 Retained profit 2024: € 44,977 ▼ 10% vs 2023 (€ 50,071) Unfavourable step	€ 51,684 Retained profit 2025: € 51,684 ▲ 15% vs 2024 (€ 44,977) Favourable step	▲ 15%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 30,000 Dividend 2023: € 30,000 Unchanged (€ 0) Unchanged	€ 35,000 Dividend 2024: € 35,000 ▲ 17% vs 2023 (€ 30,000) Unchanged	€ 30,000 Dividend 2025: € 30,000 ▼ 14% vs 2024 (€ 35,000) Unchanged	▼ 14%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 10,000 Bank debt 2024: € 10,000 Unchanged (€ 0) Unfavourable step	€ 12,000 Bank debt 2025: € 12,000 ▲ 20% vs 2024 (€ 10,000) Unfavourable step	▲ 20%
Balance sheet total	€ 74,055 Balance sheet total 2022: € 74,055 First fiscal year in the series	€ 68,397 Balance sheet total 2023: € 68,397 ▼ 8% vs 2022 (€ 74,055) Unchanged	€ 73,918 Balance sheet total 2024: € 73,918 ▲ 8% vs 2023 (€ 68,397) Unchanged	€ 81,283 Balance sheet total 2025: € 81,283 ▲ 10% vs 2024 (€ 73,918) Unchanged	▲ 10%

Key figures of Dr. Van Laer, Gastroenterologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Van Laer, Gastroenterologie?

What happened at Dr. Van Laer, Gastroenterologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 26, 2026 New annual accounts for financial year 2025: profit of € 36,707 (▲ 23% vs 2024). Source: NBB ↗
Nov 13, 2019 New establishment in Asse. KBO
Nov 13, 2019 Start of the company according to the CBE. KBO

In short

From € 26,023 profit in 2022 to € 36,707 profit in 2025.

Paid € 46,495 in corporate taxes since 2022.

Best year ever: 2025, with € 36,707 profit.

Paid out € 95,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Van Laer, Gastroenterologie? We notify you, reason included.

Follow Dr. Van Laer, Gastroenterologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Establishments

Establishment units

Physical locations of this company

Registered office

Heilsborre 21

1730 Asse

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0737.648.079
VAT number: BE 0737.648.079
Registered office: Heilsborre 21, 1730 Asse
Names & denominations: Dr. Van Laer, Gastroenterologie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 13 November 2019
Peppol: Active · Active since 25 Jun 2026

View on CBE Public ↗ Annual accounts (NBB) ↗

Dr. Van Laer, Gastroenterologie